Clinical Trial Detail

NCT ID NCT01708993
Title Reolysin in Patients With Previously Treated Advanced or Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group|Oncolytics Biotech
Indications

lung non-small cell carcinoma

Therapies

Docetaxel

Pemetrexed Disodium

Pelareorep + Pemetrexed Disodium

Docetaxel + Pelareorep

Age Groups: adult

No variant requirements are available.